# PMV Pharmaceuticals, Inc.: Form SCHEDULE 13D/A, filed Oct 27, 2025

- Company: [PMV Pharmaceuticals, Inc.](/companies/pmvp.md) (CIK 1699382)
- Form: SCHEDULE 13D/A
- Filed: 2025-10-27
- Accepted by EDGAR: Oct 27, 2025, 17:12 ET
- Period: not reported
- Accession: 0000947871-25-000926
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1699382/000094787125000926/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1699382/000094787125000926/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1699382/000094787125000926/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Oct 27, 2025.
Source: SEC EDGAR, the filing index for accession 0000947871-25-000926. Last ingested by Listed: Nov 10, 2026, 17:05 ET. No prices; not investment advice.
